PMID- 21789884 OWN - NLM STAT- MEDLINE DCOM- 20110818 LR - 20191112 IS - 0304-4920 (Print) IS - 0304-4920 (Linking) VI - 53 IP - 1 DP - 2010 Feb 28 TI - Reduction of superior mesenteric hemodynamic responsiveness to [Sar1, Thr8]-angiotensin II and bradykinin, but not sodium nitroprusside, in the presence of homocysteine infusion. PG - 45-51 AB - Hyperhomocysteinemia (HHcy) has been shown to be an independent risk factor for cardiovascular diseases, superior mesenteric thrombosis and inflammatory bowel disease. Superior mesenteric artery (SMA) supplies the intestine and reduced SMA blood flow results in intestinal ischemia. Although in vitro studies have shown that endothelium-dependent vasorelaxation of SMA is reduced in the presence of homocysteine incubation, it is not confirmed with in vivo studies. In this work, we evaluated responsiveness of SMA to endothelium-dependent or -independent vasodilators and a vasoconstrictor in the absence and presence of acute HHcy in vivo to clarify effect of HHcy on superior mesenteric vascular function. Sodium nitroprusside (SNP), bradykinin (BK), and [Sar1,Thr8]angiotensin II ([Sar1,Thr8]-ANG II) were intravenously administrated in sequence in male Sprague-Dawley rats with or without D,L-homocysteine infusion (6 mg/kg/min) through femoral vein. Agonists-induced changes in carotid artery blood pressure, superior mesenteric blood flow and vascular resistance were measured in the present study. We found that acute HHcy infusion had little effects on SNP-induced hemodynamic changes; however, BK-induced changes in blood pressure, blood flow and vascular resistance were significantly reduced in the presence of HHcy infusion. Additionally, HHcy also markedly decreased [Sar1,Thr8]-ANG II-induced superior mesenteric hemodynamic changes. These results demonstrated that responsiveness of SMA to vasoconstrictor, endothelium-dependent, but not endothelium-independent vasodilator, was inhibited in the presence of Hcy infusion. This HHcy-associated vascular hyporesponsiveness to vasoconstrictors and endothelium-dependent vasodilators may partially contribute to circulatory dysfunctions. FAU - Yen, Chia-Hung AU - Yen CH AD - Department of Life Science, National Pingtung University of Science and Technology, Pingtung. FAU - Ma, Yunn-Hwa AU - Ma YH FAU - Yu, Huang-Ping AU - Yu HP FAU - Lau, Ying-Tung AU - Lau YT LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - India TA - Chin J Physiol JT - The Chinese journal of physiology JID - 7804502 RN - 0LVT1QZ0BA (Homocysteine) RN - 11128-99-7 (Angiotensin II) RN - 169D1260KM (Nitroprusside) RN - S8TIM42R2W (Bradykinin) SB - IM MH - Angiotensin II/*pharmacology MH - Animals MH - Blood Pressure/drug effects/physiology MH - Bradykinin/*pharmacology MH - Endothelium, Vascular/drug effects/physiology MH - Hemodynamics/*drug effects/physiology MH - Homocysteine/administration & dosage/*pharmacology MH - Hyperhomocysteinemia/physiopathology MH - Infusions, Intravenous MH - Male MH - Mesenteric Artery, Superior/drug effects/*physiology MH - Models, Animal MH - Nitroprusside/*pharmacology MH - Rats MH - Rats, Sprague-Dawley MH - Regional Blood Flow/drug effects/physiology MH - Vascular Resistance/drug effects/physiology EDAT- 2010/02/28 00:00 MHDA- 2011/08/19 06:00 CRDT- 2011/07/28 06:00 PHST- 2011/07/28 06:00 [entrez] PHST- 2010/02/28 00:00 [pubmed] PHST- 2011/08/19 06:00 [medline] AID - 10.4077/cjp.2010.amh065 [doi] PST - ppublish SO - Chin J Physiol. 2010 Feb 28;53(1):45-51. doi: 10.4077/cjp.2010.amh065.